These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3115233)
1. Combined radiolabelling distribution and covalent DNA-binding studies to discriminate between a carcinogen/noncarcinogen pair of monoazo dyes related to the hepatocarcinogen butter yellow (DAB). Dashwood RH; Combes RD; Ashby J Arch Toxicol Suppl; 1987; 11():99-101. PubMed ID: 3115233 [No Abstract] [Full Text] [Related]
2. DNA-binding studies with 6BT and 5I: implications for DNA-binding/carcinogenicity and DNA-binding/mutagenicity correlations. Dashwood RH; Combes RD; Ashby J Mutat Res; 1988 Mar; 198(1):61-8. PubMed ID: 3127700 [TBL] [Abstract][Full Text] [Related]
3. The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo)benzothiazole (6BT) and 5-(p-dimethylaminophenylazo)indazole (5I) after administration to the rat. Dashwood RH; Combes RD; Ashby J Carcinogenesis; 1986 Jun; 7(6):1029-33. PubMed ID: 3085965 [TBL] [Abstract][Full Text] [Related]
4. The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I). Ashby J; Lefevre PA; Callander RD Mutat Res; 1983 Mar; 116(3-4):271-9. PubMed ID: 6403852 [TBL] [Abstract][Full Text] [Related]
5. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB). Elliott BM Carcinogenesis; 1984 Aug; 5(8):1051-5. PubMed ID: 6430584 [TBL] [Abstract][Full Text] [Related]
6. Observed convergence of the Salmonella plate and pre-incubation assays when employing varying levels of S9. Callander RD Mutagenesis; 1986 Nov; 1(6):439-43. PubMed ID: 3137416 [TBL] [Abstract][Full Text] [Related]
7. Positive and negative control observations for the in vivo/in vitro rat liver assay for unscheduled DNA synthesis (UDS). Ashby J; Trueman RW; Mohammed R; Barber G Mutagenesis; 1987 Nov; 2(6):489-90. PubMed ID: 3127659 [TBL] [Abstract][Full Text] [Related]
8. Use of an in vivo/in vitro rat liver DNA repair assay to predict the relative rodent hepatocarcinogenic potency of 3 new azo mutagens. Beije B; Ashby J Carcinogenesis; 1985 Apr; 6(4):611-5. PubMed ID: 3921275 [TBL] [Abstract][Full Text] [Related]
9. Hepatocarcinogenic activities of hydroxymethyl derivatives of 4-(N,N-dimethylamino)azobenzene in ACI/N rats. Mori H; Tanaka T; Sugie S; Kuniyasu T; Iwata H; Ni-i H; Nishiwaki A; Mori Y J Natl Cancer Inst; 1987 Nov; 79(5):1159-61. PubMed ID: 3119909 [TBL] [Abstract][Full Text] [Related]
10. Comparisons between carcinogenic potency and mutagenic potency to Salmonella in a series of derivatives of 4-dimethylaminoazobenzene (DAB). Ashby J; Lefevre PA; Styles JA; Charlesworth J; Paton D Mutat Res; 1982 Mar; 93(1):67-81. PubMed ID: 6801508 [TBL] [Abstract][Full Text] [Related]
11. Hepatic gene mutations induced in Big Blue rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT. Fletcher K; Soames AR; Tinwell H; Lefevre PA; Ashby J Environ Mol Mutagen; 1999; 34(2-3):148-53. PubMed ID: 10529739 [TBL] [Abstract][Full Text] [Related]
12. 6-p-Dimethylaminophenylazobenzothiazole: a potent hepatocarcinogen in the rat. Elliott BM; Robinson M; Ashby J Cancer Lett; 1983 Nov; 21(1):69-76. PubMed ID: 6416666 [TBL] [Abstract][Full Text] [Related]
13. Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene and their 3'-methyl-derivatives. Igarashi S; Yonekawa H; Kawajiri K; Watanabe J; Kimura T; Kodama M; Nagata C; Tagashira Y Biochem Biophys Res Commun; 1982 May; 106(1):164-9. PubMed ID: 6808998 [No Abstract] [Full Text] [Related]
14. Influence of microsomal and cytosolic fractions from the liver of 4 animal species and man on the mutagenicity of carcinogenic aminoazo dyes and nature of the mutagenicity-enhancing factor in the cytosol from rat liver. Mori Y; Niwa T; Yamazaki H; Ni-i H; Toyoshi K; Hirano K; Sugiura M Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3641-50. PubMed ID: 6441646 [No Abstract] [Full Text] [Related]
15. Mutagenicity to Salmonella of the mono methylamino and N-cyanoethyl analogues of 4-dimethylaminoazobenzene (DAB) and 6-dimethylaminophenylazobenzthiazole (6BT). Ashby J; Callander RD; Lefevre PA; Paton D; Fishwick B Mutat Res; 1984 Aug; 128(1):11-6. PubMed ID: 6433184 [TBL] [Abstract][Full Text] [Related]
16. Study on the nature of binding of dimethylaminoazobenzene with liver protein of rats fed the carcinogen. IV. Amount and nature of the polar dyes in liver protein after the administration of aminoazo dyes with the aid of stomach tube. TERAYAMA H; KUSAMA K; AOKI T Gan; 1958 Jun; 49(2):97-103. PubMed ID: 13562376 [No Abstract] [Full Text] [Related]
17. Study on the nature of binding of dimethylaminoazobenzene with liver proteins in rats fed the carcinogen. III. Comparison of the properties of natural and synthetic polar dyes. TERAYAMA H; KUSAMA K; TERUYA K; KURODA S; NAKAYAMA T Gan; 1958 Jun; 49(2):85-95. PubMed ID: 13562375 [No Abstract] [Full Text] [Related]
18. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver. Mori Y; Niwa T; Toyoshi K Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856 [TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol. Lefevre PA; Tinwell H; Ashby J Mutagenesis; 1997 Jan; 12(1):45-7. PubMed ID: 9025097 [TBL] [Abstract][Full Text] [Related]
20. The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium. Lefevre PA; Ashby J Carcinogenesis; 1981; 2(9):927-31. PubMed ID: 6794927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]